<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>Pholcodine</title><meta name="description" content="Pholcodine is an opioid cough suppressant (antitussive). It helps suppress unproductive coughs and also has a mild sedative effect, but has little or no analgesic effects. It is also known as morpholinylethylmorphine and homocodeine. Pholcodine is found in certain cough lozenges,[2] and more commonly as an oral solution, typically 5 mg / 5 ml. Adult dosage is 5-10 ml up to 3-4 times daily.[3] Pholcodine now largely replaces the previously more common codeine linctus, as it has a much lower..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/Pholcodine"/><meta property="og:title" content="Pholcodine"/><meta property="og:description" content="Pholcodine is an opioid cough suppressant (antitussive). It helps suppress unproductive coughs and also has a mild sedative effect, but has little or no analgesic effects. It is also known as morpholinylethylmorphine and homocodeine. Pholcodine is found in certain cough lozenges,[2] and more commonly as an oral solution, typically 5 mg / 5 ml. Adult dosage is 5-10 ml up to 3-4 times daily.[3] Pholcodine now largely replaces the previously more common codeine linctus, as it has a much lower..."/><meta property="og:url" content="https://grokipedia.com/page/Pholcodine"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Pholcodine"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:13.561Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Pholcodine"/><meta name="twitter:description" content="Pholcodine is an opioid cough suppressant (antitussive). It helps suppress unproductive coughs and also has a mild sedative effect, but has little or no analgesic effects. It is also known as morpholinylethylmorphine and homocodeine. Pholcodine is found in certain cough lozenges,[2] and more commonly as an oral solution, typically 5 mg / 5 ml. Adult dosage is 5-10 ml up to 3-4 times daily.[3] Pholcodine now largely replaces the previously more common codeine linctus, as it has a much lower..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="63b81be7ce416a6946c5cdd696b9e63c-e2e613e17c525804-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=63b81be7ce416a6946c5cdd696b9e63c,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.848665956987019,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pholcodine" class="transition-opacity hover:opacity-100 opacity-50">Pholcodine</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#mechanism-of-action" class="transition-opacity hover:opacity-100 opacity-50">Mechanism of action</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#metabolism-and-excretion" class="transition-opacity hover:opacity-100 opacity-50">Metabolism and excretion</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#side-effects" class="transition-opacity hover:opacity-100 opacity-50">Side effects</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#anaphylaxis-during-general-anaesthesia" class="transition-opacity hover:opacity-100 opacity-50">Anaphylaxis during general anaesthesia</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="pholcodine" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Pholcodine<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>













































































































































<!-- -->
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Pholcodine</strong> is an <span class="inline text-[1em] leading-7">opioid</span> <span class="inline text-[1em] leading-7">cough suppressant</span> (antitussive). It helps suppress unproductive <span class="inline text-[1em] leading-7">coughs</span> and also has a mild <span class="inline text-[1em] leading-7">sedative</span> effect, but has little or no <span class="inline text-[1em] leading-7">analgesic</span> effects. It is also known as morpholinylethylmorphine and homocodeine.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Pholcodine is found in certain cough <span class="inline text-[1em] leading-7">lozenges</span>,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_21qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> and more commonly as an oral solution, typically 5 mg / 5 ml. Adult dosage is 5-10 ml up to 3-4 times daily.<!-- --> Pholcodine now largely replaces the previously more common <span class="inline text-[1em] leading-7">codeine</span> linctus, as it has a much lower potential for dependence.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Pholcodine has been widely used as an antitussive agent but by 2023 concerns over its association with <span class="inline text-[1em] leading-7">anaphylaxis</span> in some circumstances meant that it has been withdrawn from sale in many territories, including the UK, EU, and Australia. In April 2025, South Africa&#x27;s SAHPRA also withdrew pholcodine-containing medicines. Pholcodine is not prescribed in the United States where it is classed as a <span class="inline text-[1em] leading-7">Schedule I</span> drug, the most highly controlled drug category.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_32abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Following the conclusion of a review of post-marketing safety data by the MHRA, all pholcodine-containing medicines are being recalled and withdrawn from the UK as a precaution.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_12qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> The available data has demonstrated that pholcodine use, particularly in the twelve months before general anesthesia with NMBAs (neuromuscular blocking agents), is a risk factor for developing an anaphylactic reaction to NMBAs. In December 2022, the <span class="inline text-[1em] leading-7">European Medicines Agency</span> recommended their withdrawal in the EU.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_32qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> As of February 2023, the Australian <span class="inline text-[1em] leading-7">Therapeutic Goods Administration</span> canceled the registration of pholcodine.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_52qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup></span>
<h1 id="mechanism-of-action" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Mechanism of action<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">Pholcodine is an opioid agonist that acts primarily on the central nervous system (CNS), particularly at mu-opioid receptors, to suppress the cough reflex by depressing the cough centre in the medulla oblongata. It has a mild sedative effect but minimal analgesic activity and less respiratory depression than morphine.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_13qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Pholcodine is contraindicated in patients with severe hepatic impairment or liver failure. Caution is advised in those with mild to moderate hepatic impairment, as its action may be prolonged.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_14abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup></span>
<h2 id="metabolism-and-excretion" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Metabolism and excretion<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Pholcodine is slowly biotransformed in the body via oxidation and conjugation to a series of metabolites that are eliminated primarily in the urine. With an average half-life of approximately 2.3 days, steady-state in someone taking the drug chronically would not be reached for nearly 2 weeks. Nearly one-half of a single dose is eventually excreted as free or conjugated parent drug. The most important urinary metabolite is <span class="inline text-[1em] leading-7">conjugated</span> <span class="inline text-[1em] leading-7">morphine</span>, which may be detectable for days or weeks after the last dose. This could trigger a positive result for opiates in a <span class="inline text-[1em] leading-7">urine drug testing</span> program.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_45abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup></span>
<h2 id="side-effects" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Side effects<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Side effects are rare and may include dizziness and gastrointestinal disturbances such as nausea or vomiting. Occasional adverse effects include constipation and drowsiness. Rare adverse effects include excitation, ataxia, and respiratory depression, which may occur after large doses or overdose. <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_16abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup></span>
<h1 id="anaphylaxis-during-general-anaesthesia" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Anaphylaxis during general anaesthesia<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">Administration of pholcodine causes production of antibodies linked with fatalities during surgery, when essential <span class="inline text-[1em] leading-7">neuromuscular blocking agents</span> (NMBAs) are administered to prevent patient movement under <span class="inline text-[1em] leading-7">general anaesthesia</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_37abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup> These antibody levels gradually fall to low levels several years after last dose of pholcodine. However, the presence of these antibodies causes a 300-fold increase in risk of <span class="inline text-[1em] leading-7">anaphylaxis</span> during anaesthesia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_57abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The link was suspected when neighbouring Norway and Sweden were found to have tenfold differences of surgical anaphylaxis deaths. Sweden had no products approved containing pholcodine, whereas 40% of the population in Norway had consumed the single approved pholcodine product.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_17qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> Norway withdrew pholcodine from the market in 2007, and the prevalence of anti-suxamethonium antibodies fell by over 80% in two years.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_27qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup> A corresponding fall in anaesthesia deaths followed.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_37qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A similar disparity exists between NMBA anaphylaxis rates in Australia, where pholcodine consumption is high and the US, where pholcodine is banned.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_18abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup> In the US, anaphylaxis rates are so low that some anaesthetists question the existence of such reactions to NMBAs.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_28abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> Conversely, Australian anaesthetists have requested a ban on pholcodine<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_38abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> due to the high anaphylaxis rate in the country.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_48abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup> However, the <span class="inline text-[1em] leading-7">Therapeutic Goods Administration</span> declined the request in January 2015,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_68abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> pending further reviews to follow. In February 2023, the Therapeutic Goods Administration reversed its previous decision and banned products containing pholcodine.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_78abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In contrast, the <span class="inline text-[1em] leading-7">European Medicines Agency</span>&#x27;s 2012 &quot;Assessment report for Pholcodine containing medicinal products&quot; concludes this: The Committee considered that evidence of an association between pholcodine use and development of NMBA-related anaphylaxis is circumstantial, not entirely consistent and therefore does not support the conclusion that there is a significant risk of cross-sensitisation to NMBAs and subsequent development of anaphylaxis during surgery.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_28qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup> A 2023 French case-control study (ALPHO) later confirmed a four-fold increased risk of NMBA-related anaphylaxis in patients exposed to pholcodine within the previous 12 months.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_38qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In September 2022, the European Medicines Agency (EMA) started reviewing its position<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_19abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> at the request of the French <span class="inline text-[1em] leading-7">ANSM</span>, which withdrew all pholcodine-containing medicines<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_39abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup> after preliminary results from a local study showed an increased risk of anaphylaxis after pholcodine use.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_49abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> The EMA review concluded on 14 December 2022 with the recommendation that pholcodine be withdrawn from the EU market.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_59abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup> This decision was ratified by the European Commission in March 2023.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_69abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup> The UK government recalled all products containing pholcodine in March 2023.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_79abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup> Subsequent withdrawals occurred in additional jurisdictions, including Singapore (June 2023), Hong Kong (effective January 2024), New Zealand (January 2024), and South Africa (April 2025).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_89abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[31]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_99abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[33]</sup></span></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="1" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Anvisa</span> (31 March 2023). <a href="https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;RDC NÂº 784 - Listas de SubstÃ¢ncias Entorpecentes, PsicotrÃ³picas, Precursoras e Outras sob Controle Especial&quot;</a> [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). <span class="inline text-[1em] leading-7">DiÃ¡rio Oficial da UniÃ£o</span> (published 4 April 2023). <a href="https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 3 August 2023. Retrieved 3 August 2023.</span></div></li><li id="2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="http://www.lloydspharmacy.com/en/potters-pholcodine-cough-pastilles" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Potter&#x27;s Pholcodine cough pastilles&quot;</a>. Lloyds Pharmacy. <a href="https://web.archive.org/web/20200229091624/http://www.lloydspharmacy.com/en/potters-pholcodine-cough-pastilles" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 29 February 2020. Retrieved 29 February 2020.</span></div></li><li id="3" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><em>British National Formulary 54</em>. London: BMJ Publishing Group Ltd., RPS Publishing. 2007. p. 175.</span></div></li><li id="4" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://web.archive.org/web/20160204232926/https://www.fda.gov/RegulatoryInformation/Legislation/ucm148726.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Legislation - Controlled Substances&quot;</a>. U.S. <span class="inline text-[1em] leading-7">Food and Drug Administration</span> (FDA). 11 June 2009. Archived from <a href="https://www.fda.gov/RegulatoryInformation/Legislation/ucm148726.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 4 February 2016.</span></div></li><li id="5" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.gov.uk/drug-safety-update/pholcodine-containing-cough-and-cold-medicines-withdrawal-from-uk-market-as-a-precautionary-measure" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Pholcodine-containing cough and cold medicines: withdrawal from UK market as a precautionary measure&quot;</a>. <em>GOV.UK</em>. 23 March 2023. <a href="https://web.archive.org/web/20231111224838/https://www.gov.uk/drug-safety-update/pholcodine-containing-cough-and-cold-medicines-withdrawal-from-uk-market-as-a-precautionary-measure" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 11 November 2023. Retrieved 11 November 2023.</span></div></li><li id="6" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ema.europa.eu/en/news/ema-recommends-withdrawal-pholcodine-medicines-eu-market" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;EMA recommends withdrawal of pholcodine medicines from EU market&quot;</a>. <em><span class="inline text-[1em] leading-7">European Medicines Agency</span> (EMA)</em>. 2 December 2022. <a href="https://web.archive.org/web/20240208063949/https://www.ema.europa.eu/en/news/ema-recommends-withdrawal-pholcodine-medicines-eu-market" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 8 February 2024. Retrieved 8 February 2024.</span></div></li><li id="7" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.tga.gov.au/safety/product-recalls/pholcodine" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Pholcodine&quot;</a>. <em><span class="inline text-[1em] leading-7">Therapeutic Goods Administration</span> (TGA)</em>. 28 February 2023. <a href="https://web.archive.org/web/20240518060851/https://www.tga.gov.au/safety/product-recalls/pholcodine" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 18 May 2024. Retrieved 18 May 2024.</span></div></li><li id="8" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.tga.gov.au/safety/information-about-specific-safety-alerts-and-recalls/about-pholcodine-cough-medicines-cancelled-tga-and-recalled-pharmacies-safety-reasons" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;About pholcodine cough medicines cancelled by the TGA and recalled from pharmacies for safety reasons&quot;</a>. <em><span class="inline text-[1em] leading-7">Therapeutic Goods Administration</span> (TGA)</em>. 1 March 2023. <a href="https://web.archive.org/web/20240518060951/https://www.tga.gov.au/safety/information-about-specific-safety-alerts-and-recalls/about-pholcodine-cough-medicines-cancelled-tga-and-recalled-pharmacies-safety-reasons" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 18 May 2024. Retrieved 18 May 2024.</span></div></li><li id="https://www.medicines.org.uk/emc/product/4921/smpc" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.medicines.org.uk/emc/product/4921/smpc" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.medicines.org.uk/emc/product/4921/smpc</a></span></div></li><li id="9" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Maurer HH, Fritz CF (December 1990). &quot;Toxicological detection of pholcodine and its metabolites in urine and hair using radio immunoassay, fluorescence polarisation immunoassay, enzyme immunoassay, and gas chromatography-mass spectrometry&quot;. <em>International Journal of Legal Medicine</em>. <strong>104</strong> (1): 43â€“6. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1007%2FBF01816483" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1007/BF01816483</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11453092" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11453092</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:5935454" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5935454</a>.</span></div></li><li id="10" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Baselt R (2008). <em>Disposition of Toxic Drugs and Chemicals in Man</em> (8th ed.). Foster City, CA: Biomedical Publications. pp. 1258â€“1260.</span></div></li><li id="https://www.medsafe.govt.nz/profs/datasheet/p/PholcodineLinctusBP.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.medsafe.govt.nz/profs/datasheet/p/PholcodineLinctusBP.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.medsafe.govt.nz/profs/datasheet/p/PholcodineLinctusBP.pdf</a></span></div></li><li id="12" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Florvaag E, Johansson SG (August 2009). &quot;The pholcodine story&quot;. <em>Immunology and Allergy Clinics of North America</em>. <strong>29</strong> (3): 419â€“27. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.iac.2009.04.002" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.iac.2009.04.002</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/19563989" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">19563989</a>.</span></div></li><li id="13" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Florvaag E, Johansson SG (July 2012). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651177" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The Pholcodine Case. Cough Medicines, IgE-Sensitization, and Anaphylaxis: A Devious Connection&quot;</a>. <em>The World Allergy Organization Journal</em>. <strong>5</strong> (7): 73â€“8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1097%2FWOX.0b013e318261eccc" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1097/WOX.0b013e318261eccc</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651177" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3651177</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23283141" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23283141</a>.</span></div></li><li id="14" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Florvaag E, Johansson SG, Irgens Ã…, de Pater GH (July 2011). &quot;IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market&quot;. <em>Allergy</em>. <strong>66</strong> (7): 955â€“60. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fj.1398-9995.2010.02518.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/j.1398-9995.2010.02518.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21241314" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21241314</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:21048759" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21048759</a>.</span></div></li><li id="15" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Sadleir PH, Clarke RC, Bunning DL, Platt PR (June 2013). <a href="https://doi.org/10.1093%2Fbja%2Faes506" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011&quot;</a>. <em>British Journal of Anaesthesia</em>. <strong>110</strong> (6): 981â€“7. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1093%2Fbja%2Faes506" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1093/bja/aes506</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23335568" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23335568</a>.</span></div></li><li id="16" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Levy JH (April 2004). <a href="https://doi.org/10.1213%2F01.ANE.0000115146.70209.4B" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Anaphylactic reactions to neuromuscular blocking drugs: are we making the correct diagnosis?&quot;</a>. <em>Anesthesia and Analgesia</em>. <strong>98</strong> (4): 881â€“2. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1213%2F01.ANE.0000115146.70209.4B" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1213/01.ANE.0000115146.70209.4B</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15041566" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15041566</a>.</span></div></li><li id="17" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Crilly H, Rose M (2014). <a href="https://doi.org/10.18773%2Faustprescr.2014.032" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Anaphylaxis and anaesthesiaâ€“can treating a cough kill?&quot;</a>. <em>Australian Prescriber</em>. <strong>37</strong> (3): 74â€“76. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.18773%2Faustprescr.2014.032" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.18773/austprescr.2014.032</a>.</span></div></li><li id="18" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Katelaris CH, Kurosawa M, Moon HB, Borres M, Florvaag E, Johansson SG (April 2014). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005347" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Pholcodine consumption and immunoglobulin E-sensitization in atopics from Australia, Korea, and Japan&quot;</a>. <em>Asia Pacific Allergy</em>. <strong>4</strong> (2): 86â€“90. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.5415%2Fapallergy.2014.4.2.86" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.5415/apallergy.2014.4.2.86</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005347" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4005347</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/24809013" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">24809013</a>.</span></div></li><li id="19" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Medew J (5 January 2015). <a href="http://www.theage.com.au/national/health/cough-medicine-alert-over-surgery-20150105-12i8sq.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cough medicine alert over surgery&quot;</a>. <em>The Age</em>. <a href="https://web.archive.org/web/20150107181404/http://www.theage.com.au/national/health/cough-medicine-alert-over-surgery-20150105-12i8sq.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 7 January 2015. Retrieved 5 January 2015.</span></div></li><li id="20" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.tga.gov.au/news/media-releases/pholcodine-cough-medicines-cancelled-tga-and-recalled-pharmacies-safety-reasons" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Pholcodine cough medicines cancelled by the TGA and recalled from pharmacies for safety reasons&quot;</a>. <em>Therapeutic Goods Administration</em>. <a href="https://web.archive.org/web/20230228033656/https://www.tga.gov.au/news/media-releases/pholcodine-cough-medicines-cancelled-tga-and-recalled-pharmacies-safety-reasons" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 28 February 2023. Retrieved 28 February 2023.</span></div></li><li id="21" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://web.archive.org/web/20171216034453/http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Pholcodine_31/WC500124716.pdf?UNLID=559983127201732412541" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Assessment report for Pholcodine containing medicinal products&quot;</a> (PDF). <em>European Medicines Agency</em>. 17 February 2012. Archived from <a href="http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Pholcodine_31/WC500124716.pdf?UNLID=559983127201732412541" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> (PDF) on 16 December 2017. Retrieved 24 March 2017.</span></div></li><li id="https://doi.org/10.1016/j.bja.2023.03.023" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://doi.org/10.1016/j.bja.2023.03.023" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://doi.org/10.1016/j.bja.2023.03.023</a></span></div></li><li id="22" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ema.europa.eu/en/news/review-pholcodine-medicines-started" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Review of pholcodine medicines started&quot;</a>. <em>European Medicines Agency</em>. 9 February 2022. <a href="https://web.archive.org/web/20221013190603/https://www.ema.europa.eu/en/news/review-pholcodine-medicines-started" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 13 October 2022. Retrieved 13 October 2022.</span></div></li><li id="23" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://ansm.sante.fr/informations-de-securite/pholcodine-suspension-des-autorisations-de-mise-sur-le-marche-et-retrait-de-toutes-les-boites-de-sirop-contenant-de-la-pholcodine-en-raison-dun-risque-dallergie-croisee-avec-les-curares" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Pholcodine: Suspension des autorisations de mise sur le marchÃ© et retrait de toutes les boÃ®tes de sirop contenant de la pholcodine en raison d&#x27;un risque d&#x27;allergie croisÃ©e avec les curares&quot;</a> [Pholcodine: Suspension of marketing authorizations and withdrawal of all boxes of syrup containing pholcodine due to a risk of cross allergy with curares]. <em>Agence nationale de sÃ©curitÃ© du mÃ©dicament et des produits de santÃ© (ANSM)</em> [<em>National Agency for the Safety of Medicines and Health Products</em>] (in French). <a href="https://web.archive.org/web/20221013190555/https://ansm.sante.fr/informations-de-securite/pholcodine-suspension-des-autorisations-de-mise-sur-le-marche-et-retrait-de-toutes-les-boites-de-sirop-contenant-de-la-pholcodine-en-raison-dun-risque-dallergie-croisee-avec-les-curares" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 13 October 2022. Retrieved 13 October 2022.</span></div></li><li id="24" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ema.europa.eu/en/documents/referral/pholcodine-containing-medicinal-products-article-107i-referral-rationale-triggering_en.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Rationale for the Triggering of Procedure Under Article 107i of Directive 2001/83/EE on Pholcodine&quot;</a> (PDF). <em>French Competent Authority (ANSM - French National Agency for Medicines and Health Products Safety) Agence nationale de sÃ©curitÃ© du mÃ©dicament et des produits de santÃ©</em>. August 2022. <a href="https://web.archive.org/web/20221012144745/https://www.ema.europa.eu/en/documents/referral/pholcodine-containing-medicinal-products-article-107i-referral-rationale-triggering_en.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> (PDF) from the original on 12 October 2022. Retrieved 13 October 2022.</span></div></li><li id="25" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ema.europa.eu/en/medicines/human/referrals/pholcodine-containing-medicinal-products" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;EMA recommends withdrawal of pholcodine medicines from EU market&quot;</a>. <em>European Medicines Agency</em>. 1 December 2022. <a href="https://web.archive.org/web/20221220090630/https://www.ema.europa.eu/en/medicines/human/referrals/pholcodine-containing-medicinal-products" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 20 December 2022. Retrieved 20 December 2022.</span></div></li><li id="26" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ema.europa.eu/en/documents/referral/pholcodine-medicines-withdrawn-eu-market_en.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Pholcodine medicines withdrawn from EU market&quot;</a> (PDF). <em>European Medicines Agency</em>. 6 March 2023. <a href="https://web.archive.org/web/20230405232436/https://www.ema.europa.eu/en/documents/referral/pholcodine-medicines-withdrawn-eu-market_en.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> (PDF) from the original on 5 April 2023. Retrieved 3 July 2023.</span></div></li><li id="27" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Medicines and Healthcare products Regulatory Agency (14 March 2023). <a href="https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-various-marketing-authorisation-holders-pholcodine-containing-products-el-23-a-slash-09" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Class 2 Medicines Recall: Various Marketing Authorisation Holders, pholcodine-containing products, EL (23)A/09&quot;</a>. <a href="https://web.archive.org/web/20230314111152/https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-various-marketing-authorisation-holders-pholcodine-containing-products-el-23-a-slash-09" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 14 March 2023. Retrieved 14 March 2023.</span></div></li><li id="https://www.hsa.gov.sg/announcements/news/withdrawal-pholcodine-containing-medicines" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.hsa.gov.sg/announcements/news/withdrawal-pholcodine-containing-medicines" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.hsa.gov.sg/announcements/news/withdrawal-pholcodine-containing-medicines</a></span></div></li><li id="https://www.info.gov.hk/gia/general/202307/07/P2023070700161.htm" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.info.gov.hk/gia/general/202307/07/P2023070700161.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.info.gov.hk/gia/general/202307/07/P2023070700161.htm</a></span></div></li><li id="https://www.medsafe.govt.nz/safety/Alerts/PholcodineConsentRevoked.asp" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.medsafe.govt.nz/safety/Alerts/PholcodineConsentRevoked.asp" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.medsafe.govt.nz/safety/Alerts/PholcodineConsentRevoked.asp</a></span></div></li><li id="https://www.sahpra.org.za/press-releases/sahpra-withdraws-pholcodine-containing-medicines-from-sa-market/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sahpra.org.za/press-releases/sahpra-withdraws-pholcodine-containing-medicines-from-sa-market/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sahpra.org.za/press-releases/sahpra-withdraws-pholcodine-containing-medicines-from-sa-market/</a></span></div></li></ol></div><div class="text-fg-secondary text-xs [&amp;_*]:mb-2"><hr class="border-border-l1 my-8 rounded-sm border-t"/>
<span class="mb-4 block break-words text-[1em] leading-7">The content is adapted from <a href="https://en.wikipedia.org/wiki/Pholcodine" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Wikipedia</a>, licensed under Creative Commons Attribution-ShareAlike 4.0 License.</span></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw" id="_R_" async=""></script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\"}]\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"Pholcodine\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"Pholcodine\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"Pholcodine\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"23:I[6367,[],\"IconMark\"]\n1f:T450,"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"** [\"Pholcodine: Suspension des autorisations de mise sur le marchÃ© et retrait de toutes les boÃ®tes de sirop contenant de la pholcodine en raison d'un risque d'allergie croisÃ©e avec les curares\"](https://ansm.sante.fr/informations-de-securite/pholcodine-suspension-des-autorisations-de-mise-sur-le-marche-et-retrait-de-toutes-les-boites-de-sirop-contenant-de-la-pholcodine-en-raison-dun-risque-dallergie-croisee-avec-les-curares) [Pholcodine: Suspension of marketing authorizations and withdrawal of all boxes of syrup containing pholcodine due to a risk of cross allergy with curares]. _Agence nationale de sÃ©curitÃ© du mÃ©dicament et des produits de santÃ© (ANSM)_ [_National Agency for the Safety of Medicines and Health Products_] (in French). [Archived](https://web.archive.org/web/20221013190555/https://ansm.sante.fr/informations-de-securite/pholcodine-suspension-des-autorisations-de-mise-sur-le-marche-et-retrait-de-toutes-les-boites-de-sirop-contenant-de-la-pholcodine-en-raison-dun-risque-dallergie-croisee-avec-les-curares) from the original on 13 October 2022. Retrieved 13 October 2022."])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"20:T457,"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"23. **^** [\"Pholcodine: Suspension des autorisations de mise sur le marchÃ© et retrait de toutes les boÃ®tes de sirop contenant de la pholcodine en raison d'un risque d'allergie croisÃ©e avec les curares\"](https://ansm.sante.fr/informations-de-securite/pholcodine-suspension-des-autorisations-de-mise-sur-le-marche-et-retrait-de-toutes-les-boites-de-sirop-contenant-de-la-pholcodine-en-raison-dun-risque-dallergie-croisee-avec-les-curares) [Pholcodine: Suspension of marketing authorizations and withdrawal of all boxes of syrup containing pholcodine due to a risk of cross allergy with curares]. _Agence nationale de sÃ©curitÃ© du mÃ©dicament et des produits de santÃ© (ANSM)_ [_National Agency for the Safety of Medicines and Health Products_] (in French). [Archived](https://web.archive.org/web/20221013190555/https://ansm.sante.fr/informations-de-securite/pholcodine-suspension-des-autorisations-de-mise-sur-le-marche-et-retrait-de-toutes-les-boites-de-sirop-contenant-de-la-pholcodine-en-raison-dun-risque-dallergie-croisee-avec-les-curares) from the original on 13 October 2022. Retrieved 13 October 2022."])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"21:T2eda,"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"# Pholcodine\n\n| **Attribute** | **Details** |\n|---------------|-------------|\n| **Clinical data** |  |\n| [Trade names](Drug_nomenclature#Trade_names \"Drug nomenclature\") | Logicin, others |\n| [AHFS](American_Society_of_Health-System_Pharmacists \"American Society of Health-System Pharmacists\")/[Drugs.com](Drugs.com \"Drugs.com\") | [International Drug Names](https://www.drugs.com/international/pholcodine.html) |\n| [Addiction liability](Addiction \"Addiction\") | Low |\n| [Routes of administration](Route_of_administration \"Route of administration\") | [By mouth](By_mouth \"By mouth\") |\n| [ATC code](Anatomical_Therapeutic_Chemical_Classification_System \"Anatomical Therapeutic Chemical Classification System\") | [R05DA08](ATC_code_R05 \"ATC code R05\") ([WHO](https://www.whocc.no/atc_ddd_index/?code=R05DA08)) |\n| **Legal status** |  |\n| [Legal status](Regulation_of_therapeutic_goods \"Regulation of therapeutic goods\") | * BR: [Class A2](Brazilian_Controlled_Drugs_and_Substances_Act#Class_A2 \"Brazilian Controlled Drugs and Substances Act\") (Narcotic drugs)[1]\u003cbr\u003e* CA: [Schedule I](Controlled_Drugs_and_Substances_Act#Schedule_I \"Controlled Drugs and Substances Act\")\u003cbr\u003e* DE: [Anlage II](Drugs_controlled_by_the_German_Narcotic_Drugs_Act#Anlage_II \"Drugs controlled by the German Narcotic Drugs Act\") (Authorized trade only, not prescriptible)\u003cbr\u003e* UK: [Class B](Drugs_controlled_by_the_UK_Misuse_of_Drugs_Act \"Drugs controlled by the UK Misuse of Drugs Act\")\u003cbr\u003e* US: [Schedule I](Controlled_Substances_Act#Schedule_I_drugs \"Controlled Substances Act\") |\n| **Pharmacokinetic data** |  |\n| [Bioavailability](Bioavailability \"Bioavailability\") | ~88% |\n| [Onset of action](Pharmacokinetics#Onset_of_action \"Pharmacokinetics\") | T\u003csub\u003emax\u003c/sub\u003e: 1.3â€“1.6 hours |\n| [Protein binding](Plasma_protein_binding \"Plasma protein binding\") | 23.5% |\n| [Metabolism](Drug_metabolism \"Drug metabolism\") | [Liver](Liver \"Liver\") |\n| [Elimination half-life](Biological_half-life \"Biological half-life\") | 32-43 hours; volume of distribution is 36-49L/kg. |\n| [Excretion](Excretion \"Excretion\") | [Kidney](Kidney \"Kidney\") |\n| **Identifiers** |  |\n| [IUPAC name](IUPAC_nomenclature_of_chemistry \"IUPAC nomenclature of chemistry\") | 7,8-Didehydro-4,5Î±-epoxy-17-methyl-3-[2-(morpholin-4-yl)ethoxy]morphinan-6Î±-ol |\n| [CAS Number](CAS_Registry_Number \"CAS Registry Number\") | [509-67-1](https://commonchemistry.cas.org/detail?cas_rn=509-67-1) |\n| [PubChem](PubChem#CID \"PubChem\") CID | [5311356](https://pubchem.ncbi.nlm.nih.gov/compound/5311356) |\n| [DrugBank](DrugBank \"DrugBank\") | [DB09209](https://www.drugbank.ca/drugs/DB09209) |\n| [ChemSpider](ChemSpider \"ChemSpider\") | [4470854](https://www.chemspider.com/Chemical-Structure.4470854.html) |\n| [UNII](Unique_Ingredient_Identifier \"Unique Ingredient Identifier\") | [LPP64AWZ7L](https://precision.fda.gov/uniisearch/srs/unii/LPP64AWZ7L) |\n| [KEGG](KEGG \"KEGG\") | [D07385](https://www.kegg.jp/entry/D07385) |\n| [ChEBI](ChEBI \"ChEBI\") | [CHEBI:53579](https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:53579) |\n| [ChEMBL](ChEMBL \"ChEMBL\") | [ChEMBL2105224](https://www.ebi.ac.uk/chembl/explore/compound/ChEMBL2105224) |\n| [CompTox Dashboard](CompTox_Chemicals_Dashboard \"CompTox Chemicals Dashboard\") (EPA) | [DTXSID70198923](https://comptox.epa.gov/dashboard/chemical/details/DTXSID70198923) |\n| [ECHA InfoCard](ECHA_InfoCard \"ECHA InfoCard\") | [100.007.367](https://echa.europa.eu/substance-information/-/substanceinfo/100.007.367) |\n| **Chemical and physical data** |  |\n| [Formula](Chemical_formula \"Chemical formula\") | C23H30N2O4 |\n| [Molar mass](Molar_mass \"Molar mass\") | 398.503 gÂ·molâˆ’1 |\n| 3D model ([JSmol](JSmol \"JSmol\")) | [Interactive image](https://chemapps.stolaf.edu/jmol/jmol.php?model=O%28c5ccc4c1c5O%5BC%40H%5D3%5BC%40%40H%5D%28O%29%5CC%3DC%2F%5BC%40H%5D2%5BC%40H%5D%28N%28C%29CC%5BC%40%40%5D123%29C4%29CCN6CCOCC6) |\n| [SMILES](Simplified_molecular-input_line-entry_system \"Simplified molecular-input line-entry system\") | O(c5ccc4c1c5O[C@H]3[C@@H](O)\\C=C/[C@H]2[C@H](N(C)CC[C@@]123)C4)CCN6CCOCC6 |\n| [InChI](International_Chemical_Identifier \"International Chemical Identifier\") | InChI=1S/C23H30N2O4/c1-24-7-6-23-16-3-4-18(26)22(23)29-21-19(5-2-15(20(21)23)14-17(16)24)28-13-10-25-8-11-27-12-9-25/h2-5,16-18,22,26H,6-14H2,1H3/t16-,17+,18-,22-,23-/m0/s1 \u003cbr\u003e Key:GPFAJKDEDBRFOS-FKQDBXSBSA-N |\n\n**Pholcodine** is an [opioid](Opioid \"Opioid\") [cough suppressant](Cough_suppressant \"Cough suppressant\") (antitussive). It helps suppress unproductive [coughs](Cough \"Cough\") and also has a mild [sedative](Sedative \"Sedative\") effect, but has little or no [analgesic](Analgesic \"Analgesic\") effects. It is also known as morpholinylethylmorphine and homocodeine. \n\nPholcodine is found in certain cough [lozenges](Throat_lozenge \"Throat lozenge\"),[2] and more commonly as an oral solution, typically 5 mg / 5 ml. Adult dosage is 5-10 ml up to 3-4 times daily.[3] Pholcodine now largely replaces the previously more common [codeine](Codeine \"Codeine\") linctus, as it has a much lower potential for dependence. \n\nPholcodine has been widely used as an antitussive agent but by 2023 concerns over its association with [anaphylaxis](Anaphylaxis \"Anaphylaxis\") in some circumstances meant that it has been withdrawn from sale in many territories, including the UK, EU, and Australia. In April 2025, South Africa's SAHPRA also withdrew pholcodine-containing medicines. Pholcodine is not prescribed in the United States where it is classed as a [Schedule I](Controlled_Substances_Act#Schedule_I_controlled_substances \"Controlled Substances Act\") drug, the most highly controlled drug category.[4]\n\nFollowing the conclusion of a review of post-marketing safety data by the MHRA, all pholcodine-containing medicines are being recalled and withdrawn from the UK as a precaution.[5] The available data has demonstrated that pholcodine use, particularly in the twelve months before general anesthesia with NMBAs (neuromuscular blocking agents), is a risk factor for developing an anaphylactic reaction to NMBAs. In December 2022, the [European Medicines Agency](European_Medicines_Agency \"European Medicines Agency\") recommended their withdrawal in the EU.[6] As of February 2023, the Australian [Therapeutic Goods Administration](Therapeutic_Goods_Administration \"Therapeutic Goods Administration\") canceled the registration of pholcodine.[7][8]\n# Mechanism of action\n\nPholcodine is an opioid agonist that acts primarily on the central nervous system (CNS), particularly at mu-opioid receptors, to suppress the cough reflex by depressing the cough centre in the medulla oblongata. It has a mild sedative effect but minimal analgesic activity and less respiratory depression than morphine.[](https://www.medicines.org.uk/emc/product/4921/smpc)\n\nPholcodine is contraindicated in patients with severe hepatic impairment or liver failure. Caution is advised in those with mild to moderate hepatic impairment, as its action may be prolonged.[](https://www.medicines.org.uk/emc/product/4921/smpc)\n## Metabolism and excretion\n\nPholcodine is slowly biotransformed in the body via oxidation and conjugation to a series of metabolites that are eliminated primarily in the urine. With an average half-life of approximately 2.3 days, steady-state in someone taking the drug chronically would not be reached for nearly 2 weeks. Nearly one-half of a single dose is eventually excreted as free or conjugated parent drug. The most important urinary metabolite is [conjugated](Drug_metabolism \"Drug metabolism\") [morphine](Morphine \"Morphine\"), which may be detectable for days or weeks after the last dose. This could trigger a positive result for opiates in a [urine drug testing](Urine_drug_test \"Urine drug test\") program.[9][10]\n## Side effects\n\nSide effects are rare and may include dizziness and gastrointestinal disturbances such as nausea or vomiting. Occasional adverse effects include constipation and drowsiness. Rare adverse effects include excitation, ataxia, and respiratory depression, which may occur after large doses or overdose. [](https://www.medsafe.govt.nz/profs/datasheet/p/PholcodineLinctusBP.pdf)\n# Anaphylaxis during general anaesthesia\n\nAdministration of pholcodine causes production of antibodies linked with fatalities during surgery, when essential [neuromuscular blocking agents](Neuromuscular_blocking_agents \"Neuromuscular blocking agents\") (NMBAs) are administered to prevent patient movement under [general anaesthesia](General_anaesthesia \"General anaesthesia\").[12] These antibody levels gradually fall to low levels several years after last dose of pholcodine. However, the presence of these antibodies causes a 300-fold increase in risk of [anaphylaxis](Anaphylaxis \"Anaphylaxis\") during anaesthesia.[13]\n\nThe link was suspected when neighbouring Norway and Sweden were found to have tenfold differences of surgical anaphylaxis deaths. Sweden had no products approved containing pholcodine, whereas 40% of the population in Norway had consumed the single approved pholcodine product.[13] Norway withdrew pholcodine from the market in 2007, and the prevalence of anti-suxamethonium antibodies fell by over 80% in two years.[14] A corresponding fall in anaesthesia deaths followed.[13]\n\nA similar disparity exists between NMBA anaphylaxis rates in Australia, where pholcodine consumption is high and the US, where pholcodine is banned.[15] In the US, anaphylaxis rates are so low that some anaesthetists question the existence of such reactions to NMBAs.[16] Conversely, Australian anaesthetists have requested a ban on pholcodine[17] due to the high anaphylaxis rate in the country.[18] However, the [Therapeutic Goods Administration](Therapeutic_Goods_Administration \"Therapeutic Goods Administration\") declined the request in January 2015,[19] pending further reviews to follow. In February 2023, the Therapeutic Goods Administration reversed its previous decision and banned products containing pholcodine.[20]\n\nIn contrast, the [European Medicines Agency](European_Medicines_Agency \"European Medicines Agency\")'s 2012 \"Assessment report for Pholcodine containing medicinal products\" concludes this: The Committee considered that evidence of an association between pholcodine use and development of NMBA-related anaphylaxis is circumstantial, not entirely consistent and therefore does not support the conclusion that there is a significant risk of cross-sensitisation to NMBAs and subsequent development of anaphylaxis during surgery.[21] A 2023 French case-control study (ALPHO) later confirmed a four-fold increased risk of NMBA-related anaphylaxis in patients exposed to pholcodine within the previous 12 months.[](https://doi.org/10.1016/j.bja.2023.03.023)\n\nIn September 2022, the European Medicines Agency (EMA) started reviewing its position[22] at the request of the French [ANSM](Agence_nationale_de_s%C3%A9curit%C3%A9_du_m%C3%A9dicament_et_des_produits_de_sant%C3%A9 \"Agence nationale de sÃ©curitÃ© du mÃ©dicament et des produits de santÃ©\"), which withdrew all pholcodine-containing medicines[23] after preliminary results from a local study showed an increased risk of anaphylaxis after pholcodine use.[24] The EMA review concluded on 14 December 2022 with the recommendation that pholcodine be withdrawn from the EU market.[25] This decision was ratified by the European Commission in March 2023.[26] The UK government recalled all products containing pholcodine in March 2023.[27] Subsequent withdrawals occurred in additional jurisdictions, including Singapore (June 2023), Hong Kong (effective January 2024), New Zealand (January 2024), and South Africa (April 2025).[](https://www.hsa.gov.sg/announcements/news/withdrawal-pholcodine-containing-medicines)[](https://www.info.gov.hk/gia/general/202307/07/P2023070700161.htm)[](https://www.medsafe.govt.nz/safety/Alerts/PholcodineConsentRevoked.asp)[](https://www.sahpra.org.za/press-releases/sahpra-withdraws-pholcodine-containing-medicines-from-sa-market/)"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761887375579,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"** [Anvisa](Brazilian_Health_Regulatory_Agency \\\"Brazilian Health Regulatory Agency\\\") (31 March 2023). [\\\"RDC NÂº 784 - Listas de SubstÃ¢ncias Entorpecentes, PsicotrÃ³picas, Precursoras e Outras sob Controle Especial\\\"](https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992) [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). [DiÃ¡rio Oficial da UniÃ£o](Di%C3%A1rio_Oficial_da_Uni%C3%A3o \\\"DiÃ¡rio Oficial da UniÃ£o\\\") (published 4 April 2023). [Archived](https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992) from the original on 3 August 2023. Retrieved 3 August 2023.\",\"description\":\"1. **^** [Anvisa](Brazilian_Health_Regulatory_Agency \\\"Brazilian Health Regulatory Agency\\\") (31 March 2023). [\\\"RDC NÂº 784 - Listas de SubstÃ¢ncias Entorpecentes, PsicotrÃ³picas, Precursoras e Outras sob Controle Especial\\\"](https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992) [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). [DiÃ¡rio Oficial da UniÃ£o](Di%C3%A1rio_Oficial_da_Uni%C3%A3o \\\"DiÃ¡rio Oficial da UniÃ£o\\\") (published 4 April 2023). [Archived](https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992) from the original on 3 August 2023. Retrieved 3 August 2023.\",\"url\":\"Brazilian_Health_Regulatory_Agency \\\"Brazilian Health Regulatory Agency\\\"\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"** [\\\"Potter's Pholcodine cough pastilles\\\"](http://www.lloydspharmacy.com/en/potters-pholcodine-cough-pastilles). Lloyds Pharmacy. [Archived](https://web.archive.org/web/20200229091624/http://www.lloydspharmacy.com/en/potters-pholcodine-cough-pastilles) from the original on 29 February 2020. Retrieved 29 February 2020.\",\"description\":\"2. **^** [\\\"Potter's Pholcodine cough pastilles\\\"](http://www.lloydspharmacy.com/en/potters-pholcodine-cough-pastilles). Lloyds Pharmacy. [Archived](https://web.archive.org/web/20200229091624/http://www.lloydspharmacy.com/en/potters-pholcodine-cough-pastilles) from the original on 29 February 2020. Retrieved 29 February 2020.\",\"url\":\"http://www.lloydspharmacy.com/en/potters-pholcodine-cough-pastilles\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"** _British National Formulary 54_. London: BMJ Publishing Group Ltd., RPS Publishing. 2007. p. 175.\",\"description\":\"3. **^** _British National Formulary 54_. London: BMJ Publishing Group Ltd., RPS Publishing. 2007. p. 175.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"** [\\\"Legislation - Controlled Substances\\\"](https://web.archive.org/web/20160204232926/https://www.fda.gov/RegulatoryInformation/Legislation/ucm148726.htm). U.S. [Food and Drug Administration](Food_and_Drug_Administration \\\"Food and Drug Administration\\\") (FDA). 11 June 2009. Archived from [the original](https://www.fda.gov/RegulatoryInformation/Legislation/ucm148726.htm) on 4 February 2016.\",\"description\":\"4. **^** [\\\"Legislation - Controlled Substances\\\"](https://web.archive.org/web/20160204232926/https://www.fda.gov/RegulatoryInformation/Legislation/ucm148726.htm). U.S. [Food and Drug Administration](Food_and_Drug_Administration \\\"Food and Drug Administration\\\") (FDA). 11 June 2009. Archived from [the original](https://www.fda.gov/RegulatoryInformation/Legislation/ucm148726.htm) on 4 February 2016.\",\"url\":\"https://web.archive.org/web/20160204232926/https://www.fda.gov/RegulatoryInformation/Legislation/ucm148726.htm\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"** [\\\"Pholcodine-containing cough and cold medicines: withdrawal from UK market as a precautionary measure\\\"](https://www.gov.uk/drug-safety-update/pholcodine-containing-cough-and-cold-medicines-withdrawal-from-uk-market-as-a-precautionary-measure). _GOV.UK_. 23 March 2023. [Archived](https://web.archive.org/web/20231111224838/https://www.gov.uk/drug-safety-update/pholcodine-containing-cough-and-cold-medicines-withdrawal-from-uk-market-as-a-precautionary-measure) from the original on 11 November 2023. Retrieved 11 November 2023.\",\"description\":\"5. **^** [\\\"Pholcodine-containing cough and cold medicines: withdrawal from UK market as a precautionary measure\\\"](https://www.gov.uk/drug-safety-update/pholcodine-containing-cough-and-cold-medicines-withdrawal-from-uk-market-as-a-precautionary-measure). _GOV.UK_. 23 March 2023. [Archived](https://web.archive.org/web/20231111224838/https://www.gov.uk/drug-safety-update/pholcodine-containing-cough-and-cold-medicines-withdrawal-from-uk-market-as-a-precautionary-measure) from the original on 11 November 2023. Retrieved 11 November 2023.\",\"url\":\"https://www.gov.uk/drug-safety-update/pholcodine-containing-cough-and-cold-medicines-withdrawal-from-uk-market-as-a-precautionary-measure\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"** [\\\"EMA recommends withdrawal of pholcodine medicines from EU market\\\"](https://www.ema.europa.eu/en/news/ema-recommends-withdrawal-pholcodine-medicines-eu-market). _[European Medicines Agency](European_Medicines_Agency \\\"European Medicines Agency\\\") (EMA)_. 2 December 2022. [Archived](https://web.archive.org/web/20240208063949/https://www.ema.europa.eu/en/news/ema-recommends-withdrawal-pholcodine-medicines-eu-market) from the original on 8 February 2024. Retrieved 8 February 2024.\",\"description\":\"6. **^** [\\\"EMA recommends withdrawal of pholcodine medicines from EU market\\\"](https://www.ema.europa.eu/en/news/ema-recommends-withdrawal-pholcodine-medicines-eu-market). _[European Medicines Agency](European_Medicines_Agency \\\"European Medicines Agency\\\") (EMA)_. 2 December 2022. [Archived](https://web.archive.org/web/20240208063949/https://www.ema.europa.eu/en/news/ema-recommends-withdrawal-pholcodine-medicines-eu-market) from the original on 8 February 2024. Retrieved 8 February 2024.\",\"url\":\"https://www.ema.europa.eu/en/news/ema-recommends-withdrawal-pholcodine-medicines-eu-market\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"** [\\\"Pholcodine\\\"](https://www.tga.gov.au/safety/product-recalls/pholcodine). _[Therapeutic Goods Administration](Therapeutic_Goods_Administration \\\"Therapeutic Goods Administration\\\") (TGA)_. 28 February 2023. [Archived](https://web.archive.org/web/20240518060851/https://www.tga.gov.au/safety/product-recalls/pholcodine) from the original on 18 May 2024. Retrieved 18 May 2024.\",\"description\":\"7. **^** [\\\"Pholcodine\\\"](https://www.tga.gov.au/safety/product-recalls/pholcodine). _[Therapeutic Goods Administration](Therapeutic_Goods_Administration \\\"Therapeutic Goods Administration\\\") (TGA)_. 28 February 2023. [Archived](https://web.archive.org/web/20240518060851/https://www.tga.gov.au/safety/product-recalls/pholcodine) from the original on 18 May 2024. Retrieved 18 May 2024.\",\"url\":\"https://www.tga.gov.au/safety/product-recalls/pholcodine\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"** [\\\"About pholcodine cough medicines cancelled by the TGA and recalled from pharmacies for safety reasons\\\"](https://www.tga.gov.au/safety/information-about-specific-safety-alerts-and-recalls/about-pholcodine-cough-medicines-cancelled-tga-and-recalled-pharmacies-safety-reasons). _[Therapeutic Goods Administration](Therapeutic_Goods_Administration \\\"Therapeutic Goods Administration\\\") (TGA)_. 1 March 2023. [Archived](https://web.archive.org/web/20240518060951/https://www.tga.gov.au/safety/information-about-specific-safety-alerts-and-recalls/about-pholcodine-cough-medicines-cancelled-tga-and-recalled-pharmacies-safety-reasons) from the original on 18 May 2024. Retrieved 18 May 2024.\",\"description\":\"8. **^** [\\\"About pholcodine cough medicines cancelled by the TGA and recalled from pharmacies for safety reasons\\\"](https://www.tga.gov.au/safety/information-about-specific-safety-alerts-and-recalls/about-pholcodine-cough-medicines-cancelled-tga-and-recalled-pharmacies-safety-reasons). _[Therapeutic Goods Administration](Therapeutic_Goods_Administration \\\"Therapeutic Goods Administration\\\") (TGA)_. 1 March 2023. [Archived](https://web.archive.org/web/20240518060951/https://www.tga.gov.au/safety/information-about-specific-safety-alerts-and-recalls/about-pholcodine-cough-medicines-cancelled-tga-and-recalled-pharmacies-safety-reasons) from the original on 18 May 2024. Retrieved 18 May 2024.\",\"url\":\"https://www.tga.gov.au/safety/information-about-specific-safety-alerts-and-recalls/about-pholcodine-cough-medicines-cancelled-tga-and-recalled-pharmacies-safety-reasons\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"** Maurer HH, Fritz CF (December 1990). \\\"Toxicological detection of pholcodine and its metabolites in urine and hair using radio immunoassay, fluorescence polarisation immunoassay, enzyme immunoassay, and gas chromatography-mass spectrometry\\\". _International Journal of Legal Medicine_. **104** (1): 43â€“6\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/BF01816483](https://doi.org/10.1007%2FBF01816483). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11453092](https://pubmed.ncbi.nlm.nih.gov/11453092). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [5935454](https://api.semanticscholar.org/CorpusID:5935454).\",\"description\":\"9. **^** Maurer HH, Fritz CF (December 1990). \\\"Toxicological detection of pholcodine and its metabolites in urine and hair using radio immunoassay, fluorescence polarisation immunoassay, enzyme immunoassay, and gas chromatography-mass spectrometry\\\". _International Journal of Legal Medicine_. **104** (1): 43â€“6\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/BF01816483](https://doi.org/10.1007%2FBF01816483). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11453092](https://pubmed.ncbi.nlm.nih.gov/11453092). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [5935454](https://api.semanticscholar.org/CorpusID:5935454).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"** Baselt R (2008). _Disposition of Toxic Drugs and Chemicals in Man_ (8th ed.). Foster City, CA: Biomedical Publications. pp. 1258â€“1260.\",\"description\":\"10. **^** Baselt R (2008). _Disposition of Toxic Drugs and Chemicals in Man_ (8th ed.). Foster City, CA: Biomedical Publications. pp. 1258â€“1260.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"** Andalo D (17 January 2015). [\\\"Anaesthetists campaign for pholcodine cough medicines to become prescription-only products\\\"](http://www.pharmaceutical-journal.com/news-and-analysis/anaesthetists-campaign-for-pholcodine-cough-medicines-to-become-prescription-only-products/20067520.article). _The Pharmaceutical Journal_. Royal Pharmaceutical Society. [Archived](https://web.archive.org/web/20160917162651/http://www.pharmaceutical-journal.com/news-and-analysis/anaesthetists-campaign-for-pholcodine-cough-medicines-to-become-prescription-only-products/20067520.article) from the original on 17 September 2016. Retrieved 17 September 2016.\",\"description\":\"11. **^** Andalo D (17 January 2015). [\\\"Anaesthetists campaign for pholcodine cough medicines to become prescription-only products\\\"](http://www.pharmaceutical-journal.com/news-and-analysis/anaesthetists-campaign-for-pholcodine-cough-medicines-to-become-prescription-only-products/20067520.article). _The Pharmaceutical Journal_. Royal Pharmaceutical Society. [Archived](https://web.archive.org/web/20160917162651/http://www.pharmaceutical-journal.com/news-and-analysis/anaesthetists-campaign-for-pholcodine-cough-medicines-to-become-prescription-only-products/20067520.article) from the original on 17 September 2016. Retrieved 17 September 2016.\",\"url\":\"http://www.pharmaceutical-journal.com/news-and-analysis/anaesthetists-campaign-for-pholcodine-cough-medicines-to-become-prescription-only-products/20067520.article\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"** Florvaag E, Johansson SG (August 2009). \\\"The pholcodine story\\\". _Immunology and Allergy Clinics of North America_. **29** (3): 419â€“27\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.iac.2009.04.002](https://doi.org/10.1016%2Fj.iac.2009.04.002). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19563989](https://pubmed.ncbi.nlm.nih.gov/19563989).\",\"description\":\"12. **^** Florvaag E, Johansson SG (August 2009). \\\"The pholcodine story\\\". _Immunology and Allergy Clinics of North America_. **29** (3): 419â€“27\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.iac.2009.04.002](https://doi.org/10.1016%2Fj.iac.2009.04.002). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19563989](https://pubmed.ncbi.nlm.nih.gov/19563989).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"_**a**_ _**b**_ _**c**_ Florvaag E, Johansson SG (July 2012). [\\\"The Pholcodine Case. Cough Medicines, IgE-Sensitization, and Anaphylaxis: A Devious Connection\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651177). _The World Allergy Organization Journal_. **5** (7): 73â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1097/WOX.0b013e318261eccc](https://doi.org/10.1097%2FWOX.0b013e318261eccc). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3651177](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651177). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23283141](https://pubmed.ncbi.nlm.nih.gov/23283141).\",\"description\":\"13. ^ _**a**_ _**b**_ _**c**_ Florvaag E, Johansson SG (July 2012). [\\\"The Pholcodine Case. Cough Medicines, IgE-Sensitization, and Anaphylaxis: A Devious Connection\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651177). _The World Allergy Organization Journal_. **5** (7): 73â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1097/WOX.0b013e318261eccc](https://doi.org/10.1097%2FWOX.0b013e318261eccc). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3651177](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651177). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23283141](https://pubmed.ncbi.nlm.nih.gov/23283141).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651177\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"** Florvaag E, Johansson SG, Irgens Ã…, de Pater GH (July 2011). \\\"IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market\\\". _Allergy_. **66** (7): 955â€“60\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1398-9995.2010.02518.x](https://doi.org/10.1111%2Fj.1398-9995.2010.02518.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21241314](https://pubmed.ncbi.nlm.nih.gov/21241314). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [21048759](https://api.semanticscholar.org/CorpusID:21048759).\",\"description\":\"14. **^** Florvaag E, Johansson SG, Irgens Ã…, de Pater GH (July 2011). \\\"IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market\\\". _Allergy_. **66** (7): 955â€“60\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1398-9995.2010.02518.x](https://doi.org/10.1111%2Fj.1398-9995.2010.02518.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21241314](https://pubmed.ncbi.nlm.nih.gov/21241314). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [21048759](https://api.semanticscholar.org/CorpusID:21048759).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"** Sadleir PH, Clarke RC, Bunning DL, Platt PR (June 2013). [\\\"Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011\\\"](https://doi.org/10.1093%2Fbja%2Faes506). _British Journal of Anaesthesia_. **110** (6): 981â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/bja/aes506](https://doi.org/10.1093%2Fbja%2Faes506). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23335568](https://pubmed.ncbi.nlm.nih.gov/23335568).\",\"description\":\"15. **^** Sadleir PH, Clarke RC, Bunning DL, Platt PR (June 2013). [\\\"Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011\\\"](https://doi.org/10.1093%2Fbja%2Faes506). _British Journal of Anaesthesia_. **110** (6): 981â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/bja/aes506](https://doi.org/10.1093%2Fbja%2Faes506). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23335568](https://pubmed.ncbi.nlm.nih.gov/23335568).\",\"url\":\"https://doi.org/10.1093%2Fbja%2Faes506\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"** Levy JH (April 2004). [\\\"Anaphylactic reactions to neuromuscular blocking drugs: are we making the correct diagnosis?\\\"](https://doi.org/10.1213%2F01.ANE.0000115146.70209.4B). _Anesthesia and Analgesia_. **98** (4): 881â€“2\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1213/01.ANE.0000115146.70209.4B](https://doi.org/10.1213%2F01.ANE.0000115146.70209.4B). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15041566](https://pubmed.ncbi.nlm.nih.gov/15041566).\",\"description\":\"16. **^** Levy JH (April 2004). [\\\"Anaphylactic reactions to neuromuscular blocking drugs: are we making the correct diagnosis?\\\"](https://doi.org/10.1213%2F01.ANE.0000115146.70209.4B). _Anesthesia and Analgesia_. **98** (4): 881â€“2\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1213/01.ANE.0000115146.70209.4B](https://doi.org/10.1213%2F01.ANE.0000115146.70209.4B). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15041566](https://pubmed.ncbi.nlm.nih.gov/15041566).\",\"url\":\"https://doi.org/10.1213%2F01.ANE.0000115146.70209.4B\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"** Crilly H, Rose M (2014). [\\\"Anaphylaxis and anaesthesiaâ€“can treating a cough kill?\\\"](https://doi.org/10.18773%2Faustprescr.2014.032). _Australian Prescriber_. **37** (3): 74â€“76\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.18773/austprescr.2014.032](https://doi.org/10.18773%2Faustprescr.2014.032).\",\"description\":\"17. **^** Crilly H, Rose M (2014). [\\\"Anaphylaxis and anaesthesiaâ€“can treating a cough kill?\\\"](https://doi.org/10.18773%2Faustprescr.2014.032). _Australian Prescriber_. **37** (3): 74â€“76\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.18773/austprescr.2014.032](https://doi.org/10.18773%2Faustprescr.2014.032).\",\"url\":\"https://doi.org/10.18773%2Faustprescr.2014.032\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"** Katelaris CH, Kurosawa M, Moon HB, Borres M, Florvaag E, Johansson SG (April 2014). [\\\"Pholcodine consumption and immunoglobulin E-sensitization in atopics from Australia, Korea, and Japan\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005347). _Asia Pacific Allergy_. **4** (2): 86â€“90\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.5415/apallergy.2014.4.2.86](https://doi.org/10.5415%2Fapallergy.2014.4.2.86). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4005347](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005347). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24809013](https://pubmed.ncbi.nlm.nih.gov/24809013).\",\"description\":\"18. **^** Katelaris CH, Kurosawa M, Moon HB, Borres M, Florvaag E, Johansson SG (April 2014). [\\\"Pholcodine consumption and immunoglobulin E-sensitization in atopics from Australia, Korea, and Japan\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005347). _Asia Pacific Allergy_. **4** (2): 86â€“90\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.5415/apallergy.2014.4.2.86](https://doi.org/10.5415%2Fapallergy.2014.4.2.86). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4005347](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005347). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24809013](https://pubmed.ncbi.nlm.nih.gov/24809013).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005347\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"** Medew J (5 January 2015). [\\\"Cough medicine alert over surgery\\\"](http://www.theage.com.au/national/health/cough-medicine-alert-over-surgery-20150105-12i8sq.html). _The Age_. [Archived](https://web.archive.org/web/20150107181404/http://www.theage.com.au/national/health/cough-medicine-alert-over-surgery-20150105-12i8sq.html) from the original on 7 January 2015. Retrieved 5 January 2015.\",\"description\":\"19. **^** Medew J (5 January 2015). [\\\"Cough medicine alert over surgery\\\"](http://www.theage.com.au/national/health/cough-medicine-alert-over-surgery-20150105-12i8sq.html). _The Age_. [Archived](https://web.archive.org/web/20150107181404/http://www.theage.com.au/national/health/cough-medicine-alert-over-surgery-20150105-12i8sq.html) from the original on 7 January 2015. Retrieved 5 January 2015.\",\"url\":\"http://www.theage.com.au/national/health/cough-medicine-alert-over-surgery-20150105-12i8sq.html\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"** [\\\"Pholcodine cough medicines cancelled by the TGA and recalled from pharmacies for safety reasons\\\"](https://www.tga.gov.au/news/media-releases/pholcodine-cough-medicines-cancelled-tga-and-recalled-pharmacies-safety-reasons). _Therapeutic Goods Administration_. [Archived](https://web.archive.org/web/20230228033656/https://www.tga.gov.au/news/media-releases/pholcodine-cough-medicines-cancelled-tga-and-recalled-pharmacies-safety-reasons) from the original on 28 February 2023. Retrieved 28 February 2023.\",\"description\":\"20. **^** [\\\"Pholcodine cough medicines cancelled by the TGA and recalled from pharmacies for safety reasons\\\"](https://www.tga.gov.au/news/media-releases/pholcodine-cough-medicines-cancelled-tga-and-recalled-pharmacies-safety-reasons). _Therapeutic Goods Administration_. [Archived](https://web.archive.org/web/20230228033656/https://www.tga.gov.au/news/media-releases/pholcodine-cough-medicines-cancelled-tga-and-recalled-pharmacies-safety-reasons) from the original on 28 February 2023. Retrieved 28 February 2023.\",\"url\":\"https://www.tga.gov.au/news/media-releases/pholcodine-cough-medicines-cancelled-tga-and-recalled-pharmacies-safety-reasons\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"** [\\\"Assessment report for Pholcodine containing medicinal products\\\"](https://web.archive.org/web/20171216034453/http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Pholcodine_31/WC500124716.pdf?UNLID=559983127201732412541) (PDF). _European Medicines Agency_. 17 February 2012. Archived from [the original](http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Pholcodine_31/WC500124716.pdf?UNLID=559983127201732412541) (PDF) on 16 December 2017. Retrieved 24 March 2017.\",\"description\":\"21. **^** [\\\"Assessment report for Pholcodine containing medicinal products\\\"](https://web.archive.org/web/20171216034453/http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Pholcodine_31/WC500124716.pdf?UNLID=559983127201732412541) (PDF). _European Medicines Agency_. 17 February 2012. Archived from [the original](http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Pholcodine_31/WC500124716.pdf?UNLID=559983127201732412541) (PDF) on 16 December 2017. Retrieved 24 March 2017.\",\"url\":\"https://web.archive.org/web/20171216034453/http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Pholcodine_31/WC500124716.pdf?UNLID=559983127201732412541\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"** [\\\"Review of pholcodine medicines started\\\"](https://www.ema.europa.eu/en/news/review-pholcodine-medicines-started). _European Medicines Agency_. 9 February 2022. [Archived](https://web.archive.org/web/20221013190603/https://www.ema.europa.eu/en/news/review-pholcodine-medicines-started) from the original on 13 October 2022. Retrieved 13 October 2022.\",\"description\":\"22. **^** [\\\"Review of pholcodine medicines started\\\"](https://www.ema.europa.eu/en/news/review-pholcodine-medicines-started). _European Medicines Agency_. 9 February 2022. [Archived](https://web.archive.org/web/20221013190603/https://www.ema.europa.eu/en/news/review-pholcodine-medicines-started) from the original on 13 October 2022. Retrieved 13 October 2022.\",\"url\":\"https://www.ema.europa.eu/en/news/review-pholcodine-medicines-started\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"$1f\",\"description\":\"$20\",\"url\":\"https://ansm.sante.fr/informations-de-securite/pholcodine-suspension-des-autorisations-de-mise-sur-le-marche-et-retrait-de-toutes-les-boites-de-sirop-contenant-de-la-pholcodine-en-raison-dun-risque-dallergie-croisee-avec-les-curares\",\"favicon\":\"\"},{\"id\":\"24\",\"title\":\"** [\\\"Rationale for the Triggering of Procedure Under Article 107i of Directive 2001/83/EE on Pholcodine\\\"](https://www.ema.europa.eu/en/documents/referral/pholcodine-containing-medicinal-products-article-107i-referral-rationale-triggering_en.pdf) (PDF). _French Competent Authority (ANSM - French National Agency for Medicines and Health Products Safety) Agence nationale de sÃ©curitÃ© du mÃ©dicament et des produits de santÃ©_. August 2022. [Archived](https://web.archive.org/web/20221012144745/https://www.ema.europa.eu/en/documents/referral/pholcodine-containing-medicinal-products-article-107i-referral-rationale-triggering_en.pdf) (PDF) from the original on 12 October 2022. Retrieved 13 October 2022.\",\"description\":\"24. **^** [\\\"Rationale for the Triggering of Procedure Under Article 107i of Directive 2001/83/EE on Pholcodine\\\"](https://www.ema.europa.eu/en/documents/referral/pholcodine-containing-medicinal-products-article-107i-referral-rationale-triggering_en.pdf) (PDF). _French Competent Authority (ANSM - French National Agency for Medicines and Health Products Safety) Agence nationale de sÃ©curitÃ© du mÃ©dicament et des produits de santÃ©_. August 2022. [Archived](https://web.archive.org/web/20221012144745/https://www.ema.europa.eu/en/documents/referral/pholcodine-containing-medicinal-products-article-107i-referral-rationale-triggering_en.pdf) (PDF) from the original on 12 October 2022. Retrieved 13 October 2022.\",\"url\":\"https://www.ema.europa.eu/en/documents/referral/pholcodine-containing-medicinal-products-article-107i-referral-rationale-triggering_en.pdf\",\"favicon\":\"\"},{\"id\":\"25\",\"title\":\"** [\\\"EMA recommends withdrawal of pholcodine medicines from EU market\\\"](https://www.ema.europa.eu/en/medicines/human/referrals/pholcodine-containing-medicinal-products). _European Medicines Agency_. 1 December 2022. [Archived](https://web.archive.org/web/20221220090630/https://www.ema.europa.eu/en/medicines/human/referrals/pholcodine-containing-medicinal-products) from the original on 20 December 2022. Retrieved 20 December 2022.\",\"description\":\"25. **^** [\\\"EMA recommends withdrawal of pholcodine medicines from EU market\\\"](https://www.ema.europa.eu/en/medicines/human/referrals/pholcodine-containing-medicinal-products). _European Medicines Agency_. 1 December 2022. [Archived](https://web.archive.org/web/20221220090630/https://www.ema.europa.eu/en/medicines/human/referrals/pholcodine-containing-medicinal-products) from the original on 20 December 2022. Retrieved 20 December 2022.\",\"url\":\"https://www.ema.europa.eu/en/medicines/human/referrals/pholcodine-containing-medicinal-products\",\"favicon\":\"\"},{\"id\":\"26\",\"title\":\"** [\\\"Pholcodine medicines withdrawn from EU market\\\"](https://www.ema.europa.eu/en/documents/referral/pholcodine-medicines-withdrawn-eu-market_en.pdf) (PDF). _European Medicines Agency_. 6 March 2023. [Archived](https://web.archive.org/web/20230405232436/https://www.ema.europa.eu/en/documents/referral/pholcodine-medicines-withdrawn-eu-market_en.pdf) (PDF) from the original on 5 April 2023. Retrieved 3 July 2023.\",\"description\":\"26. **^** [\\\"Pholcodine medicines withdrawn from EU market\\\"](https://www.ema.europa.eu/en/documents/referral/pholcodine-medicines-withdrawn-eu-market_en.pdf) (PDF). _European Medicines Agency_. 6 March 2023. [Archived](https://web.archive.org/web/20230405232436/https://www.ema.europa.eu/en/documents/referral/pholcodine-medicines-withdrawn-eu-market_en.pdf) (PDF) from the original on 5 April 2023. Retrieved 3 July 2023.\",\"url\":\"https://www.ema.europa.eu/en/documents/referral/pholcodine-medicines-withdrawn-eu-market_en.pdf\",\"favicon\":\"\"},{\"id\":\"27\",\"title\":\"** Medicines and Healthcare products Regulatory Agency (14 March 2023). [\\\"Class 2 Medicines Recall: Various Marketing Authorisation Holders, pholcodine-containing products, EL (23)A/09\\\"](https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-various-marketing-authorisation-holders-pholcodine-containing-products-el-23-a-slash-09). [Archived](https://web.archive.org/web/20230314111152/https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-various-marketing-authorisation-holders-pholcodine-containing-products-el-23-a-slash-09) from the original on 14 March 2023. Retrieved 14 March 2023.\",\"description\":\"27. **^** Medicines and Healthcare products Regulatory Agency (14 March 2023). [\\\"Class 2 Medicines Recall: Various Marketing Authorisation Holders, pholcodine-containing products, EL (23)A/09\\\"](https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-various-marketing-authorisation-holders-pholcodine-containing-products-el-23-a-slash-09). [Archived](https://web.archive.org/web/20230314111152/https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-various-marketing-authorisation-holders-pholcodine-containing-products-el-23-a-slash-09) from the original on 14 March 2023. Retrieved 14 March 2023.\",\"url\":\"https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-various-marketing-authorisation-holders-pholcodine-containing-products-el-23-a-slash-09\",\"favicon\":\"\"}],\"images\":[],\"fixedIssues\":[{\"criticality\":\"Critical\",\"issueType\":\"Internal Contradiction\",\"problematicText\":\"Addiction liability| High\",\"explanation\":\"The infobox states \\\"Addiction liability: High\\\", but the section text describes pholcodine as having \\\"a much lower potential for dependence\\\" compared to codeine, and authoritative sources (e.g., DrugBank, PubMed) confirm low or no addiction liability, with no evidence of psychological dependence or abuse potential. This contradiction misrepresents the drug's risk profile.\",\"fixedText\":\"Change infobox \\\"Addiction liability\\\" to \\\"Low\\\".\",\"evidenceSource\":\"DrugBank DB09209; PubMed 3283158\"},{\"criticality\":\"Critical\",\"issueType\":\"Quantitative/Units Error\",\"problematicText\":\"Bioavailability| Maximum plasma conc. attained 4-8 hours after oral dose.\",\"explanation\":\"The \\\"Bioavailability\\\" field incorrectly describes Tmax (time to maximum plasma concentration) instead of the fraction of dose absorbed. Actual Tmax is approximately 1.3â€“1.6 hours, not 4â€“8 hours, per pharmacokinetic studies. Bioavailability is ~88%. This error misleads on absorption kinetics.\",\"fixedText\":\"Update infobox: Change label to \\\"Absorption\\\" with \\\"Tmax: 1.3â€“1.6 hours\\\" and add \\\"Bioavailability: ~88%\\\" under Pharmacokinetic data if space allows, or correct the field to \\\"Bioavailability: Well absorbed (~88%)\\\".\",\"evidenceSource\":\"DrugBank DB09209; PMC1386567\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"Pholcodine has been widely used as an antitussive agent but by 2023 concerns over its association with anaphylaxis... withdrawn from sale in many territories.\",\"explanation\":\"The text cuts off updates at 2023, but as of April 2025, additional withdrawals occurred (e.g., South Africa by SAHPRA due to anaphylaxis risk). Current date is October 2025; omitting recent global actions presents outdated status on availability and safety concerns.\",\"fixedText\":\"Update text to include recent withdrawals, e.g., \\\"By 2025, it has been withdrawn in additional territories including South Africa.\\\"\",\"evidenceSource\":\"SAHPRA press release April 2025\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"[No specific text; overall section]\",\"explanation\":\"Missing recent regulatory actions post-2023, such as South Africa's withdrawal in April 2025, which expands the scope of global unavailability due to anaphylaxis risks. This gap affects understanding of current (2025) availability and safety profile.\",\"fixedText\":\"Add to withdrawal paragraph: \\\"In April 2025, South Africa's SAHPRA also withdrew pholcodine-containing medicines.\\\"\",\"evidenceSource\":\"SAHPRA: https://www.sahpra.org.za/press-releases/sahpra-withdraws-pholcodine-containing-medicines-from-sa-market/\"},{\"criticality\":\"Critical\",\"issueType\":\"Internal Contradiction\",\"problematicText\":\"Its use is therefore contraindicated in patients with liver disease, while care is advised in patients with hepatic impairment.\",\"explanation\":\"Hepatic impairment is a form of liver disease, making the statements mutually inconsistent regarding precautions and contraindications.\",\"fixedText\":\"Clarify contraindication to severe hepatic impairment or liver failure; advise caution in mild to moderate hepatic impairment.\",\"evidenceSource\":\"[](https://www.medicines.org.uk/emc/product/4921/smpc)\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"Its use is therefore contraindicated in patients with liver disease\",\"explanation\":\"The claim overstates the contraindication; reliable sources specify only severe hepatic impairment or liver failure as contraindicated, not all liver disease.\",\"fixedText\":\"Revise to: contraindicated in patients with severe hepatic impairment or liver failure; caution advised in those with mild to moderate hepatic impairment.\",\"evidenceSource\":\"[](https://www.medicines.org.uk/emc/product/4921/smpc)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"[None - overall section]\",\"explanation\":\"The mechanism lacks detail on pholcodine's action as an opioid agonist on mu-opioid receptors in the CNS, which is essential for understanding its antitussive effect; this gap affects completeness given the article's classification of pholcodine as an opioid.\",\"fixedText\":\"Add: Pholcodine acts as an opioid agonist, primarily at mu-opioid receptors in the CNS, suppressing the cough reflex.\",\"evidenceSource\":\"[](https://www.medicines.org.uk/emc/product/4921/smpc)\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"Pholcodine is readily absorbed from the gastrointestinal tract and freely crosses the bloodâ€“brain barrier. It acts primarily on the central nervous system (CNS), causing depression of the cough reflex, partly by a direct effect on the cough centre in the medulla. It is metabolized in the liver\",\"explanation\":\"Content on absorption, blood-brain barrier crossing, and metabolism belongs to pharmacokinetics, duplicating the separate \\\"Metabolism and excretion\\\" section per article structure; retain only core mechanism (CNS action on cough) here.\",\"fixedText\":\"Remove pharmacokinetic details (absorption, metabolism); focus solely on mechanism of CNS antitussive action.\",\"evidenceSource\":\"[Article structure provided]\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"The primary safety concerns with pholcodine revolve around death during general anaesthesia.[11]\",\"explanation\":\"This sentence discusses the primary safety concern related to anaphylaxis and death during general anaesthesia, which duplicates content intended for the dedicated \\\"Anaphylaxis during general anaesthesia\\\" section per the article structure. It misplaces key information and risks redundancy.\",\"fixedText\":\"Remove the sentence to avoid duplication; the topic is covered in the subsequent section.\",\"evidenceSource\":\"[article_structure]\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"The primary safety concerns with pholcodine revolve around death during general anaesthesia.[11]\",\"explanation\":\"Reference [11] discusses a campaign for prescription-only status due to potential fatal anaphylactic reactions but does not explicitly state \\\"death during general anaesthesia\\\" as the primary concern; it focuses on the campaign rather than comprehensive safety overview. This mismatches the strong claim made.\",\"fixedText\":\"\",\"evidenceSource\":\"\"},{\"criticality\":\"Missing Information\",\"issueType\":\"Missing Information\",\"problematicText\":\"[No specific text; general section]\",\"explanation\":\"The section lists side effects without specifying their frequencies (e.g., occasional vs. rare), which are available in authoritative sources like product datasheets. This gap affects precision in a health/safety context.\",\"fixedText\":\"Add frequencies: e.g., occasional for dizziness, drowsiness, nausea; rare for excitation, respiratory depression.\",\"evidenceSource\":\"Medsafe datasheet [](https://www.medsafe.govt.nz/profs/datasheet/p/PholcodineLinctusBP.pdf)\"},{\"criticality\":\"Non-Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"No specific text; overall section lacks updates post-2023.\",\"explanation\":\"Section covers regulatory actions up to March 2023. As of October 2025, additional withdrawals have occurred in countries like South Africa (April 2025), New Zealand (January 2024), Singapore (June 2023), and Hong Kong (effective January 2024), reflecting ongoing global response to the anaphylaxis risk. This gap affects completeness and currency for an encyclopedic article.\",\"fixedText\":\"Add a sentence or paragraph summarizing post-2023 withdrawals in additional jurisdictions, with citations to official sources, to update the global regulatory landscape.\",\"evidenceSource\":\"Web search results: SAHPRA press release (April 6, 2025); Medsafe NZ (September 25, 2023, effective 2024); HSA Singapore (June 22, 2023); Hong Kong Dept of Health (July 6, 2023).\"},{\"criticality\":\"Non-Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"No specific text; section references 2012 EMA report but not recent confirmatory studies.\",\"explanation\":\"The French ALPHO case-control study (published 2023) confirmed a four-fold increased risk of NMBA-related anaphylaxis in pholcodine users within 12 months prior, supporting the EMA's 2022 reversal. This strengthens the evidence but is absent, creating a knowledge gap on recent scientific validation.\",\"fixedText\":\"Incorporate mention of the ALPHO study after the EMA 2022 review, noting the quantified risk, with citation.\",\"evidenceSource\":\"Pholcodine exposure increases the risk of perioperative anaphylaxis to neuromuscular blocking agents: the ALPHO case-control study (British Journal of Anaesthesia, 2023; DOI: 10.1016/j.bja.2023.03.023).\"}],\"slug\":\"Pholcodine\",\"title\":\"Pholcodine\",\"content\":\"$21\",\"description\":\"Pholcodine\\n\\n| Attribute | Details |\\n|---------------|-------------|\\n| Clinical data | |\\n| Trade names | Logicin, others |\\n| AHFS/Drugs.com | International Drug Names |\\n| Addiction liability | Low |\\n|...\",\"metadata\":{\"categories\":[],\"lastModified\":\"1761553561\",\"contentLength\":\"11994\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"66394\",\"recentViews\":\"66394\",\"dailyAvgViews\":2213.13330078125,\"qualityScore\":1,\"lastViewed\":\"1761887375\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761887375578,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"Pholcodine\"],\"queryHash\":\"[\\\"page\\\",\\\"Pholcodine\\\"]\"}]},\"children\":\"$L22\"}]\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"Pholcodine\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"Pholcodine is an opioid cough suppressant (antitussive). It helps suppress unproductive coughs and also has a mild sedative effect, but has little or no analgesic effects. It is also known as morpholinylethylmorphine and homocodeine. Pholcodine is found in certain cough lozenges,[2] and more commonly as an oral solution, typically 5 mg / 5 ml. Adult dosage is 5-10 ml up to 3-4 times daily.[3] Pholcodine now largely replaces the previously more common codeine linctus, as it has a much lower...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"5\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"6\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/Pholcodine\"}],[\"$\",\"meta\",\"7\",{\"property\":\"og:title\",\"content\":\"Pholcodine\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:description\",\"content\":\"Pholcodine is an opioid cough suppressant (antitussive). It helps suppress unproductive coughs and also has a mild sedative effect, but has little or no analgesic effects. It is also known as morpholinylethylmorphine and homocodeine. Pholcodine is found in certain cough lozenges,[2] and more commonly as an oral solution, typically 5 mg / 5 ml. Adult dosage is 5-10 ml up to 3-4 times daily.[3] Pholcodine now largely replaces the previously more common codeine linctus, as it has a much lower...\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/Pholcodine\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:alt\",\"content\":\"Pholcodine\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"17\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:13.561Z\"}],[\"$\",\"meta\",\"18\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:title\",\"content\":\"Pholcodine\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:description\",\"content\":\"Pholcodine is an opioid cough suppressant (antitussive). It helps suppress unproductive coughs and also has a mild sedative effect, but has little or no analgesic effects. It is also known as morpholinylethylmorphine and homocodeine. Pholcodine is found in certain cough lozenges,[2] and more commonly as an oral solution, typically 5 mg / 5 ml. Adult dosage is 5-10 ml up to 3-4 times daily.[3] Pholcodine now largely replaces the previously more common codeine linctus, as it has a much lower...\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"23\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L23\",\"24\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"24:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"25:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="ZTk3MTQ3NTctNThmNC00NTk2LWE2OGQtYmQxMjA4NzcyY2Iw">self.__next_f.push([1,"22:[\"$\",\"$L24\",null,{\"children\":[\"$\",\"$L25\",null,{\"slug\":\"Pholcodine\"}]}]\n"])</script></body></html>